v3.25.2
Share capital
11 Months Ended 12 Months Ended
Mar. 31, 2025
Mar. 31, 2025
Mar. 31, 2024
IfrsStatementLineItems [Line Items]      
Share capital

5. Share capital

 

  

   Number of ordinary shares   Amount 
   2025   2025 
   Units   USD 
         
Issued and fully paid:          
Ordinary shares          
As at 14 May 2024 (date of incorporation)/31 March 2025   1    1 

 

The Company was incorporated on 14 May 2024 with an issued and paid up share capital of USD 1 consisting of 1 ordinary share.

 

   
Alps Life Science Inc [Member]      
IfrsStatementLineItems [Line Items]      
Share capital  

 

14. Share capital

 

   Number of ordinary shares   Amount 
   2025   2024   2025   2024 
   Units   Units   USD   USD 
                 
Issued and fully paid:                    
Ordinary shares                    
As at 1 April   58,041,998    46,698,702    13,531,607    11,127,521 
Issuance of shares during the financial year   1    140,040    -*   2,404,086 
Subdivision of shares during the financial year   -    11,203,256    -    - 
Adjustment on acquisition of subsidiaries   (58,041,998)   -    (13,531,607)   - 
Issuance of shares pursuant to investment of combining entities   58,041,990    -    580    - 
                     
As at 31 March   58,041,991    58,041,998    580    13,531,607 

 

During the financial year:

 

(a)The Company adjusted 58,041,998 ordinary shares amounting to USD13,531,607 pursuant to the acquisition of a subsidiary under common control. These shares were eliminated from equity in accordance with the accounting for common control combinations;
   
(b)The Company issued 58,041,990 new ordinary shares of USD0.00001 each at an issue price of USD0.00001 per share for a total consideration of USD580, pursuant to a capital reorganisation and as part of the consideration to satisfy the investment in combining entities under common control and the acquisition of other investments.

 

The new ordinary shares issued rank pari passu with the then existing ordinary shares of the Company.

 

The holders of ordinary shares are entitled to receive dividends as declared from time to time and are entitled to one vote per ordinary share at meetings of the Company. All ordinary shares rank equally with regard to the Company’s residual assets.

 

  * On April 11, 2024 the Company was duly incorporated with an issued and paid-up share capital of USD0.00001 comprising 1 ordinary share.

 
Cilo Cybin Holdings Limited [member]      
IfrsStatementLineItems [Line Items]      
Share capital  

 

6. SHARE CAPITAL

Share capital

 

Authorised Share capital

          
2,000,000,000 no par value Ordinary Shares no-par value 60,000,000 no par value Class A Ordinary Share   -    - 
Issued Share capital          

71,017,906 (2024: 63,916,115) Ordinary Shares no-par value

   

61,778,832

    

54,677,041

 
Share issue costs   (376,480)    (2,500,000) 
Total Issued Share Capital   58,017,352    52,177,041 
Number of Shares          
Reconciliation of number of shares in issue          
Balance at beginning of the year   63,916,115    100,000,000 
Share buy back   -    (96,449,105) 
Issued during the year   7,101,791    60,365,220 
Balance at end of year   71,017,906    63,916,115 

 

The unissued ordinary shares are under the control of the Directors subject to the provisions of the Companies Act 71 of 2008 of South Africa and the JSE Listings Requirements.

3. SHARE CAPITAL

Share capital

 

           
Authorised Share capital        
2,000,000,000 no par value Ordinary Shares no-par value   -     -  

Issued Share capital

        
63,916,115 Ordinary Shares no-par value   54,677,041    10,000 
Share issue costs   (2,500,000)   -  
Total Issued Share Capital   52,177,041    10,000